Sonic Healthcare
SHL.ASXHealth Care
Sonic Healthcare is one of the world's leading healthcare providers with a reputation for excellence in laboratory medicine/pathology, radiology & primary care medical services across Australasia, Europe & North America.
Market Data
$19.060
-0.0%$9.6B
17.6x
$1.106
5.53%
-0.2%
Latest Earnings
Preliminary Final Report
21 August 2025
Sonic Healthcare delivered FY2025 revenue of A$9,645M (+7.6% statutory, +6.1% constant currency) and net profit of A$514M (+0.5% statutory), achieving full-year guidance with normalised EBITDA margin expansion of 40bps driven by organic growth and cost efficiency. The company expects strong FY2026 earnings growth of up to ~19% EPS growth with EBITDA guidance of A$1.87-1.95B, supported by synergies from FY2024/2025 acquisitions and the recently completed LADR acquisition in Germany. Key points: Strong organic revenue growth of 5% across the group with particularly robust UK performance (14% organic growth) driven by Hertfordshire and West Essex NHS contract commenced March 2025; EBITDA margin expansion of 40bps on normalised basis despite integration of synergistic acquisitions, demonstrating successful cost efficiency programs offsetting consumables cost pressures; Cash generation improved significantly with operating cash flow up 21% to A$1,297M due to lower tax payments and improved working capital management
Recent Announcements
CEO Presentation Half Year Results to 31 December 2025
Sonic Healthcare delivered strong H1 FY2026 results with 17% revenue growth to A$5.4 billion and 11% net profit increase to A$262 million, driven by organic growth of 5% and successful acquisitions. The company maintained full-year EBITDA guidance of A$1.87-1.95 billion and demonstrated operational leverage with margin expansion across most business units. Management is progressing capital management initiatives including a A$450-500 million sale and leaseback of Brisbane hub laboratory. Key points: Strong 17% revenue growth with 5% organic growth across business; Maintained full-year EBITDA guidance demonstrating confidence; Operating leverage achieved with EBITDA margin expansion for majority of business
Media Release Half Year Results to 31 December 2025
Sonic Healthcare delivered a solid first half FY2026 performance with revenue up 17% to A$5.4B and net profit growing 11% to A$262M, driven by organic growth of 5% and recent acquisitions. The company maintained its full-year EBITDA guidance of A$1.87-1.95B on a constant currency basis and increased its interim dividend by 2.3% to 45 cents, demonstrating confidence in its diversified global operations. Key points: Strong revenue growth of 17% including organic growth of 5%; EBITDA margin enhancement for majority of the business through operating leverage and synergy realisation; Australian operations achieved 5% organic growth benefiting from Medicare indexation and private billing initiatives
Preliminary Final Report
Sonic Healthcare delivered FY2025 revenue of A$9,645M (+7.6% statutory, +6.1% constant currency) and net profit of A$514M (+0.5% statutory), achieving full-year guidance with normalised EBITDA margin expansion of 40bps driven by organic growth and cost efficiency. The company expects strong FY2026 earnings growth of up to ~19% EPS growth with EBITDA guidance of A$1.87-1.95B, supported by synergies from FY2024/2025 acquisitions and the recently completed LADR acquisition in Germany. Key points: Strong organic revenue growth of 5% across the group with particularly robust UK performance (14% organic growth) driven by Hertfordshire and West Essex NHS contract commenced March 2025; EBITDA margin expansion of 40bps on normalised basis despite integration of synergistic acquisitions, demonstrating successful cost efficiency programs offsetting consumables cost pressures; Cash generation improved significantly with operating cash flow up 21% to A$1,297M due to lower tax payments and improved working capital management
Get real-time alerts for SHL
Receive AI-powered earnings summaries and instant notifications when Sonic Healthcare releases results.
Register Free